Global SARS-CoV-2 IgG (RBD) ELISA Market Insights, Forecast to 2031

Report ID: 1668148 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 ELISA Sets
        1.2.3 ELISA Kits
    1.3 Market by Application
        1.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Disease control and prevention system
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Perspective (2017-2028)
    2.2 SARS-CoV-2 IgG (RBD) ELISA Growth Trends by Region
        2.2.1 SARS-CoV-2 IgG (RBD) ELISA Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Region (2017-2022)
        2.2.3 SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2023-2028)
    2.3 SARS-CoV-2 IgG (RBD) ELISA Market Dynamics
        2.3.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends
        2.3.2 SARS-CoV-2 IgG (RBD) ELISA Market Drivers
        2.3.3 SARS-CoV-2 IgG (RBD) ELISA Market Challenges
        2.3.4 SARS-CoV-2 IgG (RBD) ELISA Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue
        3.1.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue (2017-2022)
        3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Players (2017-2022)
    3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by SARS-CoV-2 IgG (RBD) ELISA Revenue
    3.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio
        3.4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2021
    3.5 SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Area Served
    3.6 Key Players SARS-CoV-2 IgG (RBD) ELISA Product Solution and Service
    3.7 Date of Enter into SARS-CoV-2 IgG (RBD) ELISA Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Type
    4.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Type (2017-2022)
    4.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2023-2028)
5 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Application
    5.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Application (2017-2022)
    5.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size (2017-2028)
    6.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
        6.2.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
        6.2.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028)
        6.2.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2017-2028)
    6.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
        6.3.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
        6.3.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028)
        6.3.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2017-2028)
    6.4 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
        6.4.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)
        6.4.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size (2017-2028)
    7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
        7.2.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
        7.2.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028)
        7.2.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2017-2028)
    7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
        7.3.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
        7.3.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028)
        7.3.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2017-2028)
    7.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
        7.4.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)
        7.4.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size (2017-2028)
    8.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
        8.2.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2017-2028)
    8.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
        8.3.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2017-2028)
    8.4 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region
        8.4.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size (2017-2028)
    9.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
        9.2.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
        9.2.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028)
        9.2.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2017-2028)
    9.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
        9.3.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
        9.3.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028)
        9.3.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2017-2028)
    9.4 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
        9.4.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)
        9.4.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2017-2028)
    10.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
        10.2.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Type (2017-2028)
    10.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
        10.3.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Application (2017-2028)
    10.4 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country
        10.4.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 R&D Systems
        11.1.1 R&D Systems Company Details
        11.1.2 R&D Systems Business Overview
        11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.1.5 R&D Systems Recent Developments
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Details
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.2.5 Thermo Fisher Scientific Recent Developments
    11.3 Ortho Clinical Diagnostics
        11.3.1 Ortho Clinical Diagnostics Company Details
        11.3.2 Ortho Clinical Diagnostics Business Overview
        11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.3.5 Ortho Clinical Diagnostics Recent Developments
    11.4 BD Biosciences
        11.4.1 BD Biosciences Company Details
        11.4.2 BD Biosciences Business Overview
        11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.4.5 BD Biosciences Recent Developments
    11.5 ZEUS Scientific
        11.5.1 ZEUS Scientific Company Details
        11.5.2 ZEUS Scientific Business Overview
        11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.5.5 ZEUS Scientific Recent Developments
    11.6 Bio-Rad Laboratories
        11.6.1 Bio-Rad Laboratories Company Details
        11.6.2 Bio-Rad Laboratories Business Overview
        11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.6.5 Bio-Rad Laboratories Recent Developments
    11.7 ALPCO
        11.7.1 ALPCO Company Details
        11.7.2 ALPCO Business Overview
        11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.7.4 ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.7.5 ALPCO Recent Developments
    11.8 Enzo Life Sciences
        11.8.1 Enzo Life Sciences Company Details
        11.8.2 Enzo Life Sciences Business Overview
        11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.8.5 Enzo Life Sciences Recent Developments
    11.9 BioMérieux
        11.9.1 BioMérieux Company Details
        11.9.2 BioMérieux Business Overview
        11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.9.5 BioMérieux Recent Developments
    11.10 LOEWE Biochemica
        11.10.1 LOEWE Biochemica Company Details
        11.10.2 LOEWE Biochemica Business Overview
        11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.10.5 LOEWE Biochemica Recent Developments
    11.11 Shenzhen YHLO Biotech
        11.11.1 Shenzhen YHLO Biotech Company Details
        11.11.2 Shenzhen YHLO Biotech Business Overview
        11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.11.5 Shenzhen YHLO Biotech Recent Developments
    11.12 LG
        11.12.1 LG Company Details
        11.12.2 LG Business Overview
        11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Introduction
        11.12.4 LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
        11.12.5 LG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of ELISA Sets
    Table 3. Key Players of ELISA Kits
    Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2017-2022)
    Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2023-2028)
    Table 10. SARS-CoV-2 IgG (RBD) ELISA Market Trends
    Table 11. SARS-CoV-2 IgG (RBD) ELISA Market Drivers
    Table 12. SARS-CoV-2 IgG (RBD) ELISA Market Challenges
    Table 13. SARS-CoV-2 IgG (RBD) ELISA Market Restraints
    Table 14. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Players (2017-2022)
    Table 16. Global Top SARS-CoV-2 IgG (RBD) ELISA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2021)
    Table 17. Ranking of Global Top SARS-CoV-2 IgG (RBD) ELISA Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players SARS-CoV-2 IgG (RBD) ELISA Product Solution and Service
    Table 21. Date of Enter into SARS-CoV-2 IgG (RBD) ELISA Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2017-2022)
    Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2023-2028)
    Table 27. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Application (2017-2022)
    Table 29. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Application (2023-2028)
    Table 31. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2023-2028) & (US$ Million)
    Table 61. R&D Systems Company Details
    Table 62. R&D Systems Business Overview
    Table 63. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product
    Table 64. R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 65. R&D Systems Recent Developments
    Table 66. Thermo Fisher Scientific Company Details
    Table 67. Thermo Fisher Scientific Business Overview
    Table 68. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product
    Table 69. Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 70. Thermo Fisher Scientific Recent Developments
    Table 71. Ortho Clinical Diagnostics Company Details
    Table 72. Ortho Clinical Diagnostics Business Overview
    Table 73. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product
    Table 74. Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 75. Ortho Clinical Diagnostics Recent Developments
    Table 76. BD Biosciences Company Details
    Table 77. BD Biosciences Business Overview
    Table 78. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product
    Table 79. BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 80. BD Biosciences Recent Developments
    Table 81. ZEUS Scientific Company Details
    Table 82. ZEUS Scientific Business Overview
    Table 83. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product
    Table 84. ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 85. ZEUS Scientific Recent Developments
    Table 86. Bio-Rad Laboratories Company Details
    Table 87. Bio-Rad Laboratories Business Overview
    Table 88. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product
    Table 89. Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 90. Bio-Rad Laboratories Recent Developments
    Table 91. ALPCO Company Details
    Table 92. ALPCO Business Overview
    Table 93. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product
    Table 94. ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 95. ALPCO Recent Developments
    Table 96. Enzo Life Sciences Company Details
    Table 97. Enzo Life Sciences Business Overview
    Table 98. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product
    Table 99. Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 100. Enzo Life Sciences Recent Developments
    Table 101. BioMérieux Company Details
    Table 102. BioMérieux Business Overview
    Table 103. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product
    Table 104. BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 105. BioMérieux Recent Developments
    Table 106. LOEWE Biochemica Company Details
    Table 107. LOEWE Biochemica Business Overview
    Table 108. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product
    Table 109. LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 110. LOEWE Biochemica Recent Developments
    Table 111. Shenzhen YHLO Biotech Company Details
    Table 112. Shenzhen YHLO Biotech Business Overview
    Table 113. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product
    Table 114. Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 115. Shenzhen YHLO Biotech Recent Developments
    Table 116. LG Company Details
    Table 117. LG Business Overview
    Table 118. LG SARS-CoV-2 IgG (RBD) ELISA Product
    Table 119. LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022) & (US$ Million)
    Table 120. LG Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type: 2021 VS 2028
    Figure 2. ELISA Sets Features
    Figure 3. ELISA Kits Features
    Figure 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Disease control and prevention system Case Studies
    Figure 8. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered
    Figure 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global SARS-CoV-2 IgG (RBD) ELISA Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region: 2021 VS 2028
    Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players in 2021
    Figure 13. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2021
    Figure 15. North America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2028)
    Figure 17. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2028)
    Figure 18. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Country (2017-2028)
    Figure 19. United States SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2028)
    Figure 23. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2028)
    Figure 24. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Country (2017-2028)
    Figure 25. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Region (2017-2028)
    Figure 35. China SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Country (2017-2028)
    Figure 45. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Share by Country (2017-2028)
    Figure 51. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 57. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 58. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 59. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 60. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 61. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 62. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 63. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 64. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 65. LG Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
Frequently Asked Questions
SARS-CoV-2 IgG (RBD) ELISA report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
SARS-CoV-2 IgG (RBD) ELISA report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
SARS-CoV-2 IgG (RBD) ELISA report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports